FCDCX
Price
$41.16
Change
-$0.04 (-0.10%)
Updated
Jul 31 closing price
Net Assets
7.38B
NAESX
Price
$141.37
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

FCDCX vs NAESX

FCDCX vs NAESX Comparison Chart in %
View a ticker or compare two or three
VS
FCDCX vs. NAESX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCDCX is a Buy and NAESX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NAESX has more cash in the bank: 189B vs. FCDCX (7.38B). NAESX pays higher dividends than FCDCX: NAESX (1.10) vs FCDCX (0.00). FCDCX was incepted earlier than NAESX: FCDCX (19 years) vs NAESX (66 years). FCDCX (1.89) is less costly to investors than NAESX (0.17). FCDCX is a more actively managed with annual turnover of: 46.00 vs. NAESX (17.00). FCDCX (0) and NAESX (0) have matching initial minimum investment requirements. FCDCX annual gain was more profitable for investors over the last year : 33.38 vs. NAESX (22.56). FCDCX (36.68) and NAESX (34.95) have equivalent 5 years return.
FCDCXNAESXFCDCX / NAESX
Total Expense Ratio1.890.171,112%
Annual Report Gross Expense Ratio1.890.171,112%
Fund Existence19 years66 years-
Gain YTD18.96014.563130%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets7.38B189B4%
Annual Yield % from dividends0.001.10-
Returns for 1 year33.3822.56148%
Returns for 3 years54.4743.30126%
Returns for 5 years36.6834.95105%
Returns for 10 years85.66155.2855%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMMSX32.150.39
+1.23%
Vanguard Emerg Mkts Sel Stk Inv
VRGWX936.977.54
+0.81%
Vanguard Russell 1000 Growth Index I
GIDWX20.040.13
+0.65%
Goldman Sachs US Eq Div and Premium R6
CAVAX18.710.04
+0.21%
SEI Catholic Values Equity F (SCVT)
RYOIX86.56-2.00
-2.26%
Rydex Biotechnology Inv